arrow
H

Hashim U. Ahmed

imperial college london
H指数:73
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reply to Nicholas Van As, Alison Tree, and Piet Ost’s Letter to the Editor, Drew T Bergman, Himanshu Nagar, and Timothy D McClure’s Letter to the Editor, and Richard J Bryant and Abhishek D Sharma’s Letter to the Editor re: Alexander Light, Max Peters, Archana Gopalakrishnan, et al. Oncological Outcomes Following Focal HIFU and Cryotherapy for Treatment of Nonmetastatic Prostate Cancer in the United Kingdom: An Updated Analysis of 3477 Patients from the Prospective HEAT and ICE Registries. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.05.007

回复Nicholas Van As、Alison Tree和Piet Ost致编辑的信,Drew T Bergman、Himanshu Nagar和Timothy D McClure致编辑的信,以及Richard J Bryant和Abhishek D Sharma致编辑的信,关于:Alexander Light、Max Peters、Archana Gopalakrishnan等人。在英国使用局部高强度聚焦超声和冷冻疗法治疗非转移性前列腺癌后的肿瘤学结果:对来自前瞻性HEAT和ICE登记处的3477名患者进行的更新分析。欧洲泌尿学杂志。待发表。http://dx.doi.org/10.1016/j.eururo.2026.05.007

2026-10-270
PRE
Immediate intraoperative detrusor muscle status at primary transurethral resection of bladder tumour: a prospective, blinded, paired cohort, feasibility study using fluorescence confocal microscopy (IB1-LaserComplete study)

初次经尿道膀胱肿瘤切除术中的即时术中逼尿肌肌肉状态:一项使用荧光共聚焦显微镜的前瞻性、盲法、配对队列可行性研究(IB1-LaserComplete研究)

2026-08-180
OAAI
COMPARISON OF CONTEMPORARY PATIENT SELECTION CRITERIA FOR FOCAL THERAPY: AN ANALYSIS OF 2658 PATIENTS FROM THE PROSPECTIVE HEAT AND ICE REGISTRIES

当代局部治疗患者选择标准的比较:来自前瞻性HEAT和ICE登记研究的2658例患者的分析

2026-05-010
PRE
VALIDATION OF EXISTING RISK STRATIFICATION TOOLS FOR PREDICTING TREATMENT FAILURE AFTER FOCAL THERAPY: AN ANALYSIS OF 3460 PATIENTS FROM THE HEAT AND ICE REGISTRIES

现有风险分层工具在预测局部治疗后治疗失败中的验证:HEAT和ICE登记研究的3 460例患者分析

2026-05-010
PRE
Deep learning for fluorescence confocal microscopy image interpretation in radical prostatectomy

深度学习在前列腺癌根治术荧光共聚焦显微镜图像判读中的应用

2026-04-190
OAAI
Validation of the PSMA PRIMARY Scoring System and Comparison to an E-PSMA Likert System for [68Ga]Ga-PSMA-11 PET/CT Interpretation in Men With Suspected Radiorecurrent Prostate Cancer

PSMA PRIMARY评分系统验证及其与E-PSMA李克特量表系统在疑似放射性复发性前列腺癌患者[68Ga]Ga-PSMA-11 PET/CT图像解读中的比较

2026-01-011
PRE
Reply to Gonglin Tang and Hongwei Zhao’s Letter to the Editor re: Nikhil Mayor, Alexander Light, Anna Silvanto, et al. IP8-FLUORESCE: A Prospective Paired Cohort Study Evaluating the Diagnostic Accuracy of Fluorescence Confocal Microscopy for Real-time Assessment of Surgical Margins in Radical Prostatectomy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.09.4171

回复唐公林和赵宏伟致编辑的信re: Nikhil Mayor,Alexander Light,Anna Silvanto等。IP8-FLUORESCE: 一项前瞻性配对队列研究,评估了荧光共聚焦显微镜对前列腺癌根治术中手术切缘的实时评估的诊断准确性。Eur Urol.在新闻中。https://doi.org/10.1016/j.eururo.2025.09.4171

2025-12-310
PRE
The LaserSAFE technique for margin assessment during radical prostatectomy: a feasibility study

激光SAFE技术在根治性前列腺切除术边缘评估中的应用:一项可行性研究

2025-11-010
OAAI
IP8-FLUORESCE: A Prospective Paired Cohort Study Evaluating the Diagnostic Accuracy of Fluorescence Confocal Microscopy for Real-time Assessment of Surgical Margins in Radical Prostatectomy

IP8-FLUORESCE:一项前瞻性配对队列研究,评估荧光共聚焦显微镜对根治性前列腺切除术术中实时评估手术切缘的诊断准确性。

2025-10-100
OAAI
Combination Cytoreductive Surgery, Radiotherapy, or Ablation for De Novo Metastatic Prostate Cancer: The IP2-ATLANTA Internal Pilot, Phase 2, Randomised Controlled Trial

联合细胞减灭术、放射治疗或消融术治疗原发性转移性前列腺癌:IP2-ATLANTA内部试点,II期,随机对照试验

2025-06-010
OAAI
Prostate Pathway Embedded Comparative Trial: Outcomes from the Pilot Phase of the Imperial Prostate 3—PROState Pathway Embedded Comparative Trial

前列腺通路嵌入式比较试验:帝国前列腺3—PRO前列腺通路嵌入式比较试验试点阶段的结果

2025-06-010
OAAI
Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

同时抑制TRIM24和TRIM28可增强前列腺癌细胞对雄激素拮抗剂治疗的敏感性,降低VEGF信号传导和血管生成。

2025-05-240
OAAI
Combining tissue biomarkers with mpMRI to diagnose clinically significant prostate cancer. Analysis of 21 biomarkers in the PICTURE study
2024-11-220
OAAI
Patients’ Preferences for Cytoreductive Treatments in Newly Diagnosed Metastatic Prostate Cancer: The IP5-MATTER Study

新诊断转移性前列腺癌患者对细胞减灭治疗的偏好:IP5-MATTER研究

2024-07-010
OAAI